PLA2G7 and stroke disorder: In the Clopidogrel in High-Risk Patients with Acute Non-disabling Cerebrovascular Events trial,[28] higher baseline LpPLA2 activity levels were independently associated with higher risk of 90-day stroke as well as a composite of ischemic stroke, myocardial infarction, or death.